GSK plays defense on Avandia

May 31, 2007

They are reaching out to the Lancet and WSJ.



Related posts:

  1. Avandia and meta-analysis
  2. How UnitedHealth plays hardball
  3. PHRs: Google plays catchup
  4. A 50-year old physician plays the match
  5. Mammograms before age 50
  6. In defense of surgeons
  7. The final defense against DWIs


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Comments on this entry are closed.

Previous post: The demise of Flea, who live-blogged his medical malpractice trial

Next post: Chest pain in the ER

Site Meter